Investing In BriaCell Therapeutics Corp (NASDAQ: BCTX) Stock. Performance & Trends

In the last trading session, 1.08 million BriaCell Therapeutics Corp (NASDAQ:BCTX) shares changed hands as the company’s beta touched 1.63. With the company’s per share price at $0.40 changed hands at -$0.03 or -6.74% during last session, the market valuation stood at $17.80M. BCTX’s last price was a discount, traded about -1227.5% off its 52-week high of $5.31. The share price had its 52-week low at $0.41, which suggests the last value was -2.5% down since then. When we look at BriaCell Therapeutics Corp’s average trading volume, we note the 10-day average is 1.38 million shares, with the 3-month average coming to 1.52 million.

BriaCell Therapeutics Corp (NASDAQ:BCTX) trade information

Instantly BCTX was in red as seen at the end of in last trading. With action -30.55%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -28.71%, with the 5-day performance at -30.55% in the red. However, in the 30-day time frame, BriaCell Therapeutics Corp (NASDAQ:BCTX) is -66.15% down. Looking at the short shares, we see there were 0.69 million shares sold at short interest cover period of 0.77 days.

BriaCell Therapeutics Corp (BCTX) estimates and forecasts

Data shows that the BriaCell Therapeutics Corp share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -55.88% over the past 6 months, a -248.28% in annual growth rate that is considerably lower than the industry average of 16.40%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 47.85%. The 2025 estimates are for BriaCell Therapeutics Corp earnings to decrease by -236.67%.